Episode 116: AML Series, Pt. 2 - MDS/AML Diag...

This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ...  Show more

This week, we introduce a new episode for our myeloma series, this time focusing on risk stratification and response criteria. The initial workup and surveillance labs are expansive, but all of the studies we do have a purpose. Many present-day studies also use “minimal residual ...  Show more

Consultant Rheumatologist and co-host of the Medical Take podcast, Dr Arrian ...

In the first episode of the ID:IOTS podcast Callum and Jame talk for longer than intended about everyone's favourite Gram positive coccus, Staphylococcus aureus. Audience survey: Tell us how rubbish we are here! Support the showQuestions, comments, suggestions to idiotspodcasting ...  Show more

<div><span class= "author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qowz82zpfz80zz75zz76zz88znwz72zz80zz89zz82zg1z84zvz79zz81zrl5z84zz90zz86zxlgz73zz76zn"> Welcome back to today's Friday Review where I'll be breaking down the best of the week!</span></div> <div> </div> <div> </div> <div><s ...  Show more

This is the last episode of our core curriculum series. In this episode we discuss cancer survivorship as it relates to gynecologic oncology. Additionally we provide a framework for surveillance visits as well the general timing based on primary malignancy. We also give a brief o ...  Show more